Web7 dic 2024 · The JCOG0603 trial took 13 years, with slow accrual likely reflecting patients and clinicians being hesitant to randomize to hepatectomy alone as though it was … http://www.jcog.jp/en/publications/ccsg.html
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy
Web14 set 2024 · In this phase II or III trial (JCOG0603), patients age 20-75 years with confirmed CRC and an unlimited number of liver metastatic lesions were randomly … Web6 gen 2024 · However, adjuvant mFOLFOX6 resulted in an updated 5-year OS rate of 71.2% (95% CI, 61.7% to 78.8%) vs 83.1% (95% CI, 74.9% to 88.9%) with hepatectomy alone. “Adjuvant chemotherapy with mFOLFOX6 ... embassy of ghana accra
A randomized phase II/III trial comparing hepatectomy followed …
WebThe JCOG0603 (Japan Clinical Oncology Group) study started recruitment in March 2024 and is still ongoing and recruiting patients with last follow-up established in 2024. The JCOG0603 compares postoperative mFOLFOX vs liver metastasectomy alone, and it is the only study analysing a combination chemotherapy regimen versus surgery alone. Web20 mag 2024 · The JCOG0603 trial compared hepatectomy followed by modified fluorouracil, leucovorin and oxaliplatin (mFOLFOX6) with hepatectomy alone in CLM, and preliminary data were presented at the 2024 ... Web29 mag 2024 · O ensaio clínico randomizado de Fase II/II JCOG0603, buscou determinar se o tratamento adjuvante com FOLFOX modificado (mFOLFOX) é superior à hepatectomia isolada para metástases hepáticas do câncer colorretal. Os resultados apresentados no ASCO 2024 mostraram que a quimioterapia pós-operatória com mFOLFOX6 melhora a … embassy of ghana berne